title: Anticipating the arrival of low-penetrance genetic testing to primary care medicine.
abstract: Primary prevention is a pillar of primary care medicine. Furthermore, the identification of commonly occurring genetic mutations that confer only modest increases in disease risk (i.e., low-penetrance mutations or LPMs) is expanding our conception of how genetic testing supports prevention goals. To date, most predictive genetic testing has focused on identifying the minority of patients who carry mutations that significantly increase their risk for developing future disease (i.e., high-penetrance mutations or HPMs). Genetic tests for LPMs are more similar in structure and purpose to commonly used biomarker tests like lipid testing than to HPM testing. In the primary care setting, LPM testing will likely be presented to patients as one part of a multifactorial risk assessment that contains only a small amount of genetics-specific information. Consequently, preparing primary care clinicians for the anticipated use of LPM genetic tests will not require development of a completely new skill set but rather a re-conceptualization of both genetic testing and biomarker evaluation for primary prevention.
authors: Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, 300 N. Ingalls Street, Room 6D19, Ann Arbor, MI, 48109-0456, USA, btarini@med.umich.edu.
authors: Beth A
authors: BA
authors: Tarini
authors: Nicole
authors: N
authors: Exe
authors: Brian J
authors: BJ
authors: Zikmund-Fisher
references: J Clin Oncol. 2004 Mar 15;22(6):1055-62
references: 14981104
references: JAMA. 2001 Nov 14;286(18):2251-6
references: 11710890
references: Am J Med Genet. 2001 Fall;106(3):216-22
references: 11778982
references: Br J Cancer. 2004 Nov 15;91(10):1787-94
references: 15505627
references: Breast J. 2009 Jan-Feb;15(1):61-8
references: 19120380
references: Nat Genet. 2009 Jun;41(6):677-87
references: 19430479
references: Nature. 2003 Apr 24;422(6934):835-47
references: 12695777
references: Diabetologia. 2009 Apr;52(4):568-70
references: 19214469
references: JAMA. 2007 Oct 10;298(14):1682-4
references: 17925520
references: JAMA. 2001 May 16;285(19):2486-97
references: 11368702
references: Am J Hum Genet. 2003 Mar;72(3):636-49
references: 12592605
references: Lancet. 2001 Mar 3;357(9257):709-12
references: 11247571
references: J Clin Invest. 2008 May;118(5):1590-605
references: 18451988
references: Emerg Themes Epidemiol. 2011 Jun 09;8(1):5
references: 21658235
references: BMC Cancer. 2008 Nov 07;8:326
references: 18992148
references: N Engl J Med. 2000 Jul 13;343(2):141-4
references: 10891526
references: Circulation. 2008 Feb 12;117(6):743-53
references: 18212285
references: Genet Test. 2007 Fall;11(3):249-55
references: 17949286
references: Annu Rev Genomics Hum Genet. 2004;5:1-14
references: 15485341